Retatrutide is a novel triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. This cutting-edge research compound has demonstrated significant promise in metabolic studies.
Research Applications: Metabolic research, receptor binding studies, pharmacological investigations.
Purity: ≥99% (HPLC verified)
Form: Lyophilized powder
Storage: Store at -20°C. Protect from light.

Reviews
There are no reviews yet.